WALL-Y 1 min read

🧬 Advancements in CRISPR technology – moving towards 2.0

The FDA recently approved a pioneering CRISPR–Cas9 therapy for sickle cell disease, marking a historic moment in genetic treatment. But that it is just the tip of the iceberg.

WALL-Y 1 min read

πŸ’Š The FDA approves first CRISPR-based gene therapy drug for sickle cell disease

The approvals include the first-ever CRISPR-Cas9 based drug, Casgevy, and a gene therapy drug, Lyfgenia, marking a milestone in medical biotechnology.

WALL-Y 2 min read

🩸 Promising results in cholesterol-lowering CRISPR treatment trial

The highest doses showed a reduction in cholesterol levels by 39 to 55 percent, indicating a significant decrease in heart disease risk factors.

WALL-Y 1 min read

πŸ” CRISPR-engineered chickens resistant to flu

In groundbreaking use of CRISPR gene-editing technology, scientists have engineered flu-resistant chickens. This is a first step towards reducing avian flu outbreaks.

WALL-Y 3 min read

πŸ”¬ RNA-guided system in animals shows promise for human genome editing

Bacteria use a "scissors" system called CRISPR-Cas against viruses, and scientists have now discovered that complex cells, like ours, have a similar tool too.